What is Dichroa Febrifuga?
Dichroa Febrifuga is a medicinal plant native to Southeast Asia and southern China. Revered for its potent therapeutic properties, the root of this plant has been a cornerstone in traditional Chinese medicine. Known for its bitter taste and profound effects on fever and malaria, Dichroa Febrifuga has transcended folk medicine to garner scientific interest. It is now widely recognized for its potential applications in immune modulation, antimicrobial therapy, and overall health support.
Active Ingredients
Febrifugine
Febrifugine is a quinazolinone alkaloid that serves as the primary active compound. Febrifugine exhibits potent antimalarial activity, disrupting the replication cycle of the malaria parasite. Its effects also extend to immune system modulation.
Isotetrandrine
A bis benzylisoquinoline alkaloid known for its anti-inflammatory and antioxidant properties. This compound supports respiratory health by reducing inflammation and oxidative stress in lung tissues.
Dichroine
An alkaloid with demonstrated hepatoprotective effects. Dichroine has been studied for its potential to safeguard liver cells against damage while aiding detoxification processes.
Common Sources
Plant-Based Sources
Dichroa Febrifuga Root: The primary source of active compounds, highly concentrated in febrifugine and isotetrandrine.
Other Related Species: Alkaloids similar to those in Dichroa Febrifuga are found in plants within the Hydrangeaceae family.
How Does it Work?
Dichroa Febrifuga extract operates primarily through its alkaloid constituents, particularly febrifugine and isotetrandrine, which demonstrate significant biological activity. The compound’s main mechanism involves interference with parasitic metabolism for antimalarial effects, while simultaneously modulating inflammatory pathways through cytokine regulation and immune cell production enhancement.
The extract’s therapeutic action extends to hepatic protection through multiple pathways. Its active compounds reduce oxidative stress in liver tissue while promoting cellular repair mechanisms, complemented by the extract’s ability to support immune function through enhanced leukocyte production and improved immunological response to pathogens. These combined mechanisms establish Dichroa Febrifuga as a multi-target therapeutic agent.
How to Produce Dichroa Febrifuga Powder?
Harvesting: Roots of Dichroa Febrifuga are carefully harvested from mature plants.
Extraction: Alkaloids are extracted using ethanol or methanol solvents to ensure maximum yield.
Purification: Advanced techniques like chromatography separate active ingredients from impurities, achieving high purity.
Drying and Powdering: The purified extract is dried and milled into a fine powder, ensuring consistency in particle size for diverse applications.
Bulk Dichroa Febrifuga Specifications Sheet
Specification | Details |
Type | Plant extract |
Appearance | Yellowish-brown fine powder |
Active Ingredient | Febrifugine, Isotetrandrine |
Purity | 98%+ |
Solubility | Soluble in water and ethanol |
Certifications | ISO available. Please contact our sales team for more information. |
Test Methods | HPLC, UV-Vis, etc. |
MOQ (Minimum Order Qty) | 1kg |
Sample Availability | Available (10-20g/bag) |
OEM Service | Available (capsules, tablets) |
ODM Service | Available |
Private Label | Available |
Contract Manufacturing | Available |
Dichroa Febrifuga: Benefits, Side Effects, and More
Immune System Enhancement
Dichroa Febrifuga benefits include significant immunomodulatory effects through multiple cellular pathways, primarily through the stimulation of leukocyte production and enhancement of immune cell activity. The extract’s alkaloid components trigger increased production of various white blood cells, including lymphocytes and macrophages, while simultaneously optimizing their functional capacity. This dual-action mechanism results in improved pathogen recognition, enhanced immune response efficiency, and strengthened overall immune system resilience against various infectious agents.
Respiratory System Support
The extract’s respiratory benefits center on isotetrandrine’s ability to modulate inflammatory responses within bronchial tissues. This compound effectively reduces airway inflammation through multiple mechanisms, including suppression of pro-inflammatory cytokine production, modulation of bronchial smooth muscle reactivity, and regulation of mucus production. These combined actions make it particularly effective in managing chronic respiratory conditions, where its anti-inflammatory properties help maintain optimal airway function and reduce symptomatic episodes.
Hepatoprotective Action
The hepatoprotective effects of this powder are primarily mediated through dichroine’s antioxidant and cell-regenerative properties. This compound actively neutralizes free radicals within hepatic tissue, while simultaneously stimulating cellular repair mechanisms and enhancing liver enzyme function. The extract’s ability to support liver cell regeneration, combined with its protection against oxidative stress, provides comprehensive support for hepatic health and detoxification processes.
Antimalarial Properties
It exhibits potent antimalarial activity through direct interference with Plasmodium parasite metabolism and reproduction cycles. The compound’s mechanism involves disruption of parasite protein synthesis and metabolic pathways, effectively preventing parasite multiplication within host cells. This specific action, combined with its rapid onset and high efficacy, positions it as a valuable component in malaria treatment protocols, particularly in regions where drug resistance is a concern.
Antimicrobial Function
The extract’s antimicrobial properties stem from its complex alkaloid profile, which demonstrates broad-spectrum activity against various pathogenic organisms. These compounds disrupt bacterial cell membranes, interfere with microbial protein synthesis, and inhibit fungal growth through multiple mechanisms. The extract’s natural antimicrobial action provides an alternative to conventional antibiotics, particularly valuable in cases where bacterial resistance or synthetic antibiotic contraindications are concerns.
Side Effects
Gastrointestinal Distress: Mild nausea or upset stomach may occur.
Liver Sensitivity: High doses could induce hepatotoxicity.
Is it Legal?
United States
The FDA categorizes Dichroa Febrifuga under dietary supplement regulations (21 CFR 111), permitting its use in supplement formulations while restricting therapeutic claims without formal drug approval processes.
European Union
The European Medicines Agency (EMA) and EFSA authorize Dichroa Febrifuga in accordance with Traditional Herbal Medicinal Product guidelines, requiring standardized safety documentation and quality assurance protocols.
Japan
MHLW (Ministry of Health, Labour and Welfare) recognizes Dichroa Febrifuga within traditional medicine parameters, implementing specific quality control requirements and usage guidelines for therapeutic applications.
Australia
The TGA (Therapeutic Goods Administration) lists Dichroa Febrifuga under the ARTG (Australian Register of Therapeutic Goods) complementary medicine category, mandating comprehensive safety data and manufacturing compliance documentation.
Recommended Dosage and Usage
Dietary Supplements: 100-500 mg/day, divided into two or three doses.
Topical Applications: Concentration ranges between 0.5%-2% for skincare formulations.
How to Store Dichroa Febrifuga Powder?
The storage of this powder requires strict environmental control protocols. The compound should be maintained in airtight containers under refrigeration, protected from light, moisture, and temperature variations. These storage conditions are essential for preserving the chemical stability and biological activity of the compound’s active constituents.
Dichroa Febrifuga VS Artemisinin
Dichroa Febrifuga and Artemisinin demonstrate distinct therapeutic profiles in antimalarial treatment and beyond. While both compounds effectively target malaria parasites, their mechanisms and broader applications differ significantly. Dichroa Febrifuga operates through febrifugine, which disrupts parasite metabolism while simultaneously providing immunomodulatory effects through enhanced white blood cell production and activation. This dual-action mechanism extends its therapeutic potential beyond antimalarial applications.
Artemisinin exhibits more rapid antimalarial action through its endoperoxide bridge structure, which generates reactive oxygen species specifically toxic to Plasmodium parasites. However, its therapeutic scope remains primarily focused on malaria treatment. Unlike Dichroa Febrifuga, it lacks significant immunomodulatory or hepatoprotective properties.
The compounds also differ in their additional health benefits. Dichroa Febrifuga demonstrates notable hepatoprotective effects through dichroine’s antioxidant properties, while also providing broad-spectrum antimicrobial activity. These multiple mechanisms of action establish it as a more versatile therapeutic agent, though Artemisinin maintains superiority in rapid malaria treatment protocols.
Feature | Dichroa Febrifuga | Artemisinin |
CAS Number | 477-37-2 | 63968-64-9 |
Molecular Formula | C17H19N3O3 | C15H22O5 |
Molecular Weight | 313.35 g/mol | 282.34 g/mol |
Primary Sources | Dichroa Febrifuga | Artemisia annua |
Primary Uses | Immune support | Malaria treatment |
Bioavailability | Medium | Low |
Dichroa Febrifuga VS Curcumin
The therapeutic relationship between Dichroa Febrifuga and Curcumin presents an interesting study in complementary mechanisms. These compounds share certain inflammatory pathway targets while maintaining distinct specialized functions. In inflammatory modulation, Curcumin demonstrates extensively documented effects on NF-κB pathways and cytokine regulation, supported by numerous clinical studies. Its long-term safety profile and broad acceptance in therapeutic applications make it a preferred choice for chronic inflammatory conditions.
Dichroa Febrifuga approaches inflammation through different molecular targets, particularly through isotetrandrine’s action on specific inflammatory mediators. However, its distinguishing feature lies in its antimalarial efficacy and immune system modulation, areas where Curcumin shows limited activity. The compound’s ability to enhance leukocyte production while simultaneously targeting malarial parasites sets it apart in therapeutic applications.
The bioavailability profiles and absorption mechanisms of these compounds also differ significantly. Curcumin, despite its well-documented therapeutic potential, faces challenges with absorption and requires specific formulation strategies to enhance bioavailability. Dichroa Febrifuga’s active compounds demonstrate more favorable natural absorption characteristics, though its overall therapeutic applications require further clinical validation compared to the extensively studied Curcumin.
Both compounds show promise in their respective therapeutic niches, with Curcumin excelling in chronic inflammatory conditions and Dichroa Febrifuga offering unique combinations of antimalarial, immune-modulating, and anti-inflammatory properties. Their different molecular targets and mechanisms suggest potential synergistic applications in certain therapeutic contexts, particularly where both inflammation modulation and immune system enhancement are desired outcomes.
Conclusion
Dichroa Febrifuga demonstrates significant therapeutic potential through its diverse profile of bioactive alkaloids, particularly febrifugine, isotetrandrine, and dichroine. The extract’s documented efficacy in antimalarial activity, immune modulation, respiratory support, and hepatoprotection, combined with its established safety profile and regulatory compliance across major markets, positions it as a versatile therapeutic agent. Its standardized production methods, favorable absorption characteristics, and multiple mechanisms of action support its implementation across various applications, from pharmaceutical formulations to nutraceutical products, while ongoing research continues to validate both traditional applications and identify new therapeutic possibilities.
Why choose Nutri Avenue Supplier to Buy Atractylodes Extract Powder?
When it comes to sourcing Atractylodes Extract Powder, don’t settle for ordinary when you can have the extraordinary. At Nutri Avenue, we combine unmatched quality with tailored solutions to ensure your success. Our ISO-certified and GMP-compliant processes guarantee every batch meets the highest standards of purity and consistency, giving your brand the edge it deserves.
What truly sets us apart is our flexible OEM/ODM services, designed to bring your vision to life. Whether crafting a new product or refining an existing line, we provide customized solutions that fit your unique needs. Add to that competitive pricing, certified quality, and expert support, and you’ll see why Nutri Avenue is the partner of choice for leading brands worldwide.
ISO certificates are readily available for all of Nutri Avenue’s products.
Frequently Asked Questions
Can it be used daily?
Yes, within recommended dosages. Consult a healthcare provider for prolonged use.
Is it vegan-friendly?
Yes, it is plant-based and suitable for vegans.
What makes it unique?
Its dual antimalarial and immune-boosting properties stand out.
Can it improve skin health?
Yes, it reduces oxidative stress and enhances hydration in topical applications.
How long can it be stored?
Properly stored powder remains stable for up to two years.